中文名 | 盐酸帕罗西汀半水合物 |
英文名 | Paroxetine HCl Hemihydrate |
别名 | 盐酸帕罗西汀 半水帕罗西汀 D4-盐酸帕罗西汀 盐酸帕罗西汀半水合物 盐酸帕罗西汀半水合物, 选择性5-羟色胺重吸收抑制剂 (SSRI) (办证)盐酸帕罗西汀PAROXETINE HYDROCHLORIDE HEMIHYDRAT (-)-反式-4R-(4-氟苯基)-3S-{[3',4'-(亚甲二氧基)苯氧基]甲基}-哌啶盐酸盐半水合物 (3S,4R)-3-((苯并[D][1,3]DIOXOL-5-氧基)甲基)-4-(4-氟苯基)哌啶盐酸盐半水合物 |
英文别名 | PAROXETINE-D4 HCL Paroxetine HCl Hemihydrate Paroxetine-D4 hydrochloride Paroxetine Hydrochloride (350 mg) paroxetine hydrochloride Hemihydrate PAROXETINE-D4 HCL kf-yuwen(at)kf-chem.com (-)-(3S,4R)-PAROXETINE HYDROCHLORIDE HEMIHYDRATE 1,3-benzodioxol-5-yl-[4-(4-fluorophenyl)-3-piperidinyl]methanol hydrochloride (3s-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride Hemihydrate |
CAS | 110429-35-1 |
EINECS | 000-000-0 |
化学式 | C19H17ClD4FNO3 |
分子量 | 369.85 |
InChI | InChI=1/C19H20FNO3.ClH/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;/h1-6,9,14,17,21H,7-8,10-12H2;1H/t14?,17-;/m0./s1 |
熔点 | 121-131 C |
沸点 | 451.7℃ at 760mmHg |
溶解度 | 微溶于水,易溶于甲醇,微溶于乙醇 (96%) 和二氯甲烷。 |
存储条件 | under inert gas (nitrogen or Argon) at 2-8°C |
外观 | 粉末 |
颜色 | white |
最大波长(λmax) | 292nm(H2O)(lit.) |
Merck | 14,7043 |
体外研究 | Paroxetine (1 μM and 10 μM) distinctly restrains T cell migration induced by CX3CL1 through inhibiting GRK2. Paroxetine inhibits GRK2 induced activation of ERK. Paroxetine (10 μM) reduces pro-inflammatory cytokines in LPS-stimulated BV2 cells. Paroxetine (0-5 μM) leads to a dose-dependent inhibition on LPS-induced production of TNF-α and IL-1β in BV2 cells. Paroxetine also inhibits lipopolysaccharide (LPS)-induced nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression in BV2 cells. Paroxetine (5 μM) blocks LPS-induced JNK activation and attenuates baseline ERK1/2 activity in BV2 cells. Paroxetine relieves microglia-mediated neurotoxicity, and suppresses LPS-stimulated pro-inflammatory cytokines and NO in primary microglial cells. |
体内研究 | Paroxetine treatment obviously attenuates the symptoms of CIA rats. Paroxetine treatment clearly prevents the histological damage of joints and alleviates T cells infiltration into synovial tissue. Paroxetine reveals a strong effect on inhibiting CX3CL1 production in synovial tissues. Paroxetine (20 mg/kg/day) reduces the myocyte cross-sectional area in rat and ROS formation in the remote myocardium. Paroxetine reduces the susceptibility to ventricular tachycardia. Paroxetine treatment following MI decreases LV remodeling and susceptibility to arrhythmias, probably by reducing ROS formation. In CCI paroxetine-treated group, paroxetine (10 mg/kg, i.p.) produces hyperalgesia at days 7 and 10 (P<0.01), but a decrease in pain behavior is seen at day 14. Moreover, paroxetine (10 mg/kg) significantly attenuates tactile hypersensitivity when compared to CCI vehicle-treated group. |
危险品标志 | F - 易燃物品 C - 腐蚀性物品 Xn - 有害物品 |
风险术语 | R11 - 高度易燃。 R34 - 引起灼伤。 R36/37/38 - 刺激眼睛、呼吸系统和皮肤。 R22 - 吞食有害。 |
安全术语 | S16 - 远离火源。 S26 - 不慎与眼睛接触后,请立即用大量清水冲洗并征求医生意见。 S36/37/39 - 穿戴适当的防护服、手套和护目镜或面具。 S45 - 若发生事故或感不适,立即就医(可能的话,出示其标签)。 S36 - 穿戴适当的防护服。 |
危险品运输编号 | UN 3077 9 / PGIII |
WGK Germany | 3 |
RTECS | TM4569320 |
海关编号 | 29349990 |
Hazard Class | IRRITANT |
下游产品 | 帕罗西汀 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!